Atlas Trials

Zilong Yuan

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zilong Yuan

RecordFirmDate
Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma (NCT06854107)Zilong Yuan2023-12-01

Track Zilong Yuan automatically

Every clearance here is in the API, with alerts when new ones post.